New weight loss drug begins human testing
Disease control
Recruiting now
This early-stage study is testing a new drug called ALV-100 to see if it's safe for people to take and how their bodies process it. Researchers will enroll 180 overweight or obese adults, some with type 2 diabetes, to receive different doses or a placebo. The main goal is to chec…
Phase: PHASE1 • Sponsor: Alveus Therapeutics, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC